1. REPORT
2. ESAP METADATE
3. INFORMATION ABOUT THE ENTITY
4. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
POLISH FINANCIAL SUPERVISION AUTHORITY |
|||||||||||
|
UNI - EN REPORT No |
31 | / |
2026 |
|
||||||
Date of issue: |
2026-07-20 |
||||||||||
Short name of the issuer |
|||||||||||
KRKA |
|||||||||||
Subject |
|||||||||||
Start of share buy-back programme |
|||||||||||
Official market - legal basis |
|||||||||||
Art. 17 ust. 1 Rozporządzenia MAR – informacje poufne |
|||||||||||
Unofficial market - legal basis |
|||||||||||
Contents of the report: |
|||||||||||
On 9 July 2026, the 32nd Annual General Meeting authorized the Management Board for the acquisition of treasury shares in accordance with the paragraph 1, indent 8 of Article 247 of the Companies Act (ZGD-1). The company is disclosing that it will commence the acquisition of treasury shares in accordance with this authorization under the following conditions: * The sole purpose of a share buy-back programme is share capital decrease of the issuer. * The maximum pecuniary amount allocated to the programme is EUR 251,902,480. * The maximum number of shares to be acquired is 762,763. * Duration of the programme is 36 months from the date of the General Meeting authorization. Shares will be acquired according to the enclosed six-month share buy-back programme schedule until the end of 2026, on the regulated market at the respective market price and on terms that will not affect prevailing market conditions. The company will announce the continuation of the share buy-back programme with a new six-month share buy-back schedule at least 30 days before the expiration of valid schedule. The public will be regularly informed about these acquisitions of treasury shares. The notice will be published on the Company's website (www.krka.biz) from 20 July 2026 onwards, for a period of at least 5 years. |
|||||||||||
Annexes |
|||||||||||
File |
Description |
||||||||||
Share buy-back programme schedule from July to December 2026.pdf |
Share buy-back programme schedule from July to December 2026 |
||||||||||
Legal framework |
Type of information |
||||
TRANSD |
Acquisition or disposal of an issuer’s own shares |
||||
RegulatoryData |
|||||
Collection Body |
PLKNF |
||||
Unique data record identifier |
|||||
Type of submission |
New (to be used for new information) |
||||
Voluntary information flag |
|||||
Date or period covered [Date or beginning of the period to which the information relates] |
2026-07-20 |
||||
Date or period covered [Date or end of the period to which the information relates] |
2026-07-20 |
||||
Personal data flag |
|||||
Macierzyste państwo członkowskie, w stosownych przypadkach |
PL |
||||
DocumentReference |
|||||
Język, w którym przekazano informacje |
Oryginał (ORIG) czy tłumaczenie (TRAN) |
Numer referencyjny pliku danych |
|||
PL |
ORIG |
||||
SubmittingEntity |
|||||
Submitting entity LEI |
or |
Submitting entity name - natural person |
|||
RelatedEntity/LegalPerson |
|||||
Entity LEI |
Size of the entity |
Industry sector(s) |
|||
549300H9RLRTRTLRUZ73 |
Large group |
(acc. NACE): C |
|||
KRKA, TOVARNA ZDRAVIL D.D. |
|||||||||||||
(fullname of the issuer) |
|||||||||||||
KRKA |
Farmaceutyczny (far) |
||||||||||||
(short name of the issuer) |
(sector according to clasification of the WSE in Warsow) |
||||||||||||
8501 |
Nove Mesto |
||||||||||||
(post code) |
(city) |
||||||||||||
Smarjeska |
6 | ||||||||||||
(street) |
(number) |
||||||||||||
+386 7 331 21 11 |
+386 7 332 15 37 |
||||||||||||
(phone number) |
(fax) |
||||||||||||
(e-mail) |
(web site) |
||||||||||||
nie dotyczy |
|||||||||||||
(NIP) |
(REGON) |
||||||||||||
SIGNATURE OF PERSONS REPRESENTING THE COMPANY |
|||||
Date |
Name |
Position / Function |
Signature |
||
2026-07-20 |
Jože Colarič |
President of the Management Board and CEO |
|||